Michael Fuller works in the field of Psychiatry. He received 1 awards: "CMS Meaningful Use Stage 1 Certification". Michael Fuller is a published doctor. He published 1 publication, including: 'Evaluation of the dopamine -hydroxylase (DH) inhibitor nepicastat in participants who meet criteria for cocaine use disorder.' Michael A. Fuller accepts Medicare payments and is registered with Medicare.gov.
![]() |
Dr. Cindy L. Wigg, MD
![]() ![]() |
![]() |
Dr. George Schlagenhauf, MD |
![]() |
Dr. Jean M. Goodwin, MD
![]() ![]() |
![]() |
Dr. Lisa M. Vela, MD
![]() |
![]() |
Dr. Charles C. Barnhart Jr., MD |
![]() |
Dr. Linea A. McNeel, MD
![]() |
![]() |
Dr. Aaron J. Alaniz, MD |
![]() |
Dr. Lauren S. Douglas, MD |
![]() |
Dr. Thomas P. Fletcher, MD |
![]() |
Dr. Geoffrey B. Hauger, MD |
![]() |
Dr. Mili M. Khandheria, MD
![]() |
![]() |
Dr. Derek W. Neal, MD |
![]() |
Dr. Cody R. McMahan, MD |
![]() |
Dr. Holly Shiao, MD |
![]() |
Dr. Joseph S. Shotwell, MD |